News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
407,849 Results
Type
Article (25282)
Company Profile (317)
Press Release (382244)
Multimedia
Podcasts (90)
Webinars (13)
Section
Business (113003)
Career Advice (727)
Deals (20531)
Drug Delivery (68)
Drug Development (63358)
Employer Resources (88)
FDA (9088)
Job Trends (7907)
News (203998)
Policy (16147)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1692)
Academic (1)
Accelerated approval (21)
Adcomms (21)
Allergies (110)
Alliances (30804)
ALS (147)
Alzheimer's disease (1269)
Antibody-drug conjugate (ADC) (261)
Approvals (9318)
Artificial intelligence (333)
Autoimmune disease (126)
Automation (15)
Bankruptcy (162)
Best Places to Work (6575)
BIOSECURE Act (10)
Biosimilars (131)
Biotechnology (237)
Bladder cancer (116)
Brain cancer (52)
Breast cancer (459)
Cancer (3687)
Cardiovascular disease (319)
Career advice (626)
Career pathing (18)
CAR-T (237)
CDC (24)
Celiac Disease (1)
Cell therapy (611)
Cervical cancer (22)
Clinical research (54722)
Collaboration (1328)
Company closure (2)
Compensation (639)
Complete response letters (46)
COVID-19 (1814)
CRISPR (88)
C-suite (640)
Cystic fibrosis (121)
Data (5152)
Denatured (23)
Depression (116)
Diabetes (385)
Diagnostics (2831)
Digital health (16)
Diversity (9)
Diversity, equity & inclusion (32)
Drug discovery (208)
Drug pricing (100)
Drug shortages (19)
Duchenne muscular dystrophy (226)
Earnings (42690)
Editorial (39)
Employer branding (9)
Employer resources (82)
Events (66621)
Executive appointments (753)
FDA (11286)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (1123)
Gene editing (188)
Generative AI (28)
Gene therapy (538)
GLP-1 (795)
Government (2085)
Grass and pollen (5)
Guidances (237)
Healthcare (10661)
HIV (44)
Huntington's disease (44)
IgA nephropathy (79)
Immunology and inflammation (213)
Immuno-oncology (46)
Indications (83)
Infectious disease (1980)
Inflammatory bowel disease (170)
Inflation Reduction Act (13)
Influenza (68)
Intellectual property (178)
Interviews (119)
IPO (9695)
IRA (30)
Job creations (1621)
Job search strategy (539)
JPM (48)
Kidney cancer (11)
Labor market (38)
Layoffs (314)
Leadership (20)
Legal (3013)
Liver cancer (59)
Longevity (13)
Lung cancer (477)
Lymphoma (284)
Machine learning (28)
Management (26)
Manufacturing (492)
MASH (148)
Medical device (5463)
Medtech (5489)
Mergers & acquisitions (11602)
Metabolic disorders (1011)
Multiple sclerosis (133)
NASH (17)
Neurodegenerative disease (260)
Neuropsychiatric disorders (80)
Neuroscience (2330)
Neurotech (1)
NextGen: Class of 2026 (3535)
Non-profit (2212)
Now hiring (36)
Obesity (468)
Opinion (168)
Ovarian cancer (144)
Pain (133)
Pancreatic cancer (181)
Parkinson's disease (254)
Partnered (21)
Patents (329)
Patient recruitment (374)
Peanut (48)
People (37601)
Pharmaceutical (50)
Pharmacy benefit managers (14)
Phase 1 (17438)
Phase 2 (24508)
Phase 3 (17753)
Pipeline (3874)
Policy (168)
Postmarket research (1679)
Preclinical (7313)
Press Release (61)
Prostate cancer (193)
Psychedelics (53)
Radiopharmaceuticals (250)
Rare diseases (724)
Real estate (2639)
Recruiting (33)
Regulatory (14094)
Reports (24)
Research institute (1581)
Resumes & cover letters (96)
Rett syndrome (24)
RNA editing (21)
RSV (42)
Schizophrenia (137)
Series A (202)
Series B (149)
Service/supplier (3)
Sickle cell disease (85)
Special edition (19)
Spinal muscular atrophy (139)
Sponsored (21)
Startups (2598)
State (1)
Stomach cancer (8)
Supply chain (52)
Tariffs (34)
The Weekly (66)
Vaccines (640)
Venture capital (75)
Weight loss (280)
Women's health (42)
Worklife (9)
Date
Today (53)
Last 7 days (399)
Last 30 days (1406)
Last 365 days (21448)
2026 (2021)
2025 (21723)
2024 (24837)
2023 (27543)
2022 (34699)
2021 (36632)
2020 (32622)
2019 (26046)
2018 (19484)
2017 (20123)
2016 (18425)
2015 (22253)
2014 (16170)
2013 (12181)
2012 (12613)
2011 (12909)
2010 (11925)
Location
Africa (365)
Alabama (68)
Alaska (4)
Arizona (114)
Arkansas (7)
Asia (26313)
Australia (4582)
California (7950)
Canada (2155)
China (902)
Colorado (288)
Connecticut (296)
Delaware (266)
Europe (66782)
Florida (1087)
Georgia (282)
Hawaii (2)
Idaho (32)
Illinois (550)
India (46)
Indiana (299)
Iowa (11)
Japan (317)
Kansas (88)
Kentucky (23)
Louisiana (16)
Maine (20)
Maryland (915)
Massachusetts (6136)
Michigan (147)
Minnesota (340)
Mississippi (3)
Missouri (63)
Montana (19)
Nebraska (11)
Nevada (58)
New Hampshire (30)
New Jersey (2060)
New Mexico (18)
New York (2090)
North Carolina (994)
North Dakota (6)
Northern California (3917)
Ohio (221)
Oklahoma (14)
Oregon (28)
Pennsylvania (1476)
Puerto Rico (11)
Rhode Island (28)
South America (540)
South Carolina (19)
Southern California (3131)
Tennessee (67)
Texas (1095)
United States (27385)
Utah (138)
Virginia (185)
Washington D.C. (43)
Washington State (684)
West Virginia (1)
Wisconsin (60)
Wyoming (2)
407,849 Results for "peptide therapeutics group plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform
January 13, 2026
·
7 min read
Press Releases
Swiss Rockets Group and Alloy Therapeutics Partner to Advance Radioligand Therapeutics in Oncology
January 12, 2026
·
3 min read
Press Releases
Salarius Pharmaceuticals Changes Corporate Name to Decoy Therapeutics and Nasdaq Ticker Symbol to DCOY Reflecting Focus on Next-Generation Peptide Conjugate Therapeutics
January 8, 2026
·
5 min read
Press Releases
Salarius Pharmaceuticals Announces Planned Corporate Name and Ticker Symbol Change to Decoy Therapeutics, Reflecting Strategic Pivot to Next-Generation Antiviral and Peptide-Conjugate Platform
December 19, 2025
·
6 min read
Press Releases
CelLBxHealth PLC Announces Board Changes
January 12, 2026
·
4 min read
Press Releases
Agilent Research Catalyst (ARC) Award Presented to UC Davis for Breakthroughs in Peptide Therapeutics
November 13, 2025
·
3 min read
Press Releases
Genflow Biosciences PLC Announces Directorate Change
January 19, 2026
·
6 min read
Press Releases
AdvanCell Announces Collaboration and Exclusive Licensing Agreement with 48Hour Discovery to Develop a Novel Peptide-Based Lead-212 Radiotherapeutic for a Gastrointestinal Cancer with Significant Medical Need
February 2, 2026
·
3 min read
Press Releases
Animate Biosciences Launches Breakthrough Generative AI Platform Revolutionizing Inflammatory and Fibrotic Disease Treatment Through Peptide Therapeutics
November 14, 2025
·
3 min read
Press Releases
EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide
December 9, 2025
·
2 min read
1 of 40,785
Next
